long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
Published 1 year ago • 93 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
5:12
the current standard of care in advanced stage hl
-
1:35
long-term outcomes for patients with ptcl: 10-year follow-up analysis
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
2:32
updates from the avenue trial: avelumab for advanced classical hl
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:13
the allg cml13 ascend-cml study: high major molecular responses with asciminib treatment for cp-cml
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
0:32
patient selection for ctcl